At SVAX, we are your trusted partner in biotechnology, dedicated to transforming healthcare through the innovation, research, development, and manufacturing of cutting-edge vaccines and biologics.
As pioneers in the biotech industry, we are building more than just life-saving products. We are shaping a thriving biotech ecosystem that attracts global investment and drives regional innovation. With state-of-the-art facilities, we deliver world-class active biological ingredients and finished formulations, addressing unmet medical needs with precision and care.
Join us on our journey to advance health, empower communities, and set new standards of excellence in biotechnology.
Together, we’re creating a healthier future.
To position Saudi Arabia as a global leader in biomanufacturing, achieving self-sufficiency and equitable access to vaccines and life-saving biologics across Saudi Arabia, GCC, and OIC countries.
To localize biomanufacturing by creating a sustainable supply of vaccines and life-saving biologics, enhancing pandemic preparedness, and empowering national talents to lead the biotechnology sector’s growth in alignment with the Saudi Vision 2030 and the National Biotechnology Strategy.
Our Scientific & Advisory Committee unites experts in biotechnology and pharmaceuticals to provide strategic guidance and ensure our initiatives reflect the latest scientific advancements. This committee drives excellence and innovation, shaping our mission to advance impactful solutions in healthcare and biomanufacturing.
Our Nomination & Remuneration Committee oversees the selection and development of leadership, ensuring that our team aligns with our strategic goals. It establishes fair remuneration practices and fosters a culture of excellence and accountability across our organization.
Our Risk & Audit Committee ensures robust risk management and compliance across our organization. It oversees financial reporting, internal controls, and regulatory adherence, promoting transparency and accountability in all operations.
Regulatory Affairs
Business Development
The world faces a significant unmet need for vaccines and biologics to combat infectious diseases and ensure equitable access to care. In the member countries of the Organization of Islamic Cooperation (OIC), this challenge is even more pronounced. These nations often contend with limited access to vaccines, biologics and therapeutics developed for global markets, coupled with a lack of solutions addressing local health challenges that are overlooked by the global industry.
At the heart of this disparity lies a chronic gap in local discovery, development, and manufacturing capabilities. This profound need inspired the creation of SVAX.
As a proud member of the G20, Saudi Arabia is uniquely positioned to lead. With its socio-economic influence and visionary framework outlined in Saudi Vision 2030 and the National Biotechnology Strategy, Saudi Arabia is driving innovation, fostering economic diversification, and prioritizing public health. SVAX is honored to contribute to this transformative journey by addressing critical healthcare challenges, advancing pandemic preparedness, and ensuring access to life-saving solutions for our region and beyond.
Together, we aim to redefine healthcare and create a legacy of innovation, resilience, and impact.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.